The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Open accessAbstract
BACKGROUND: Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia. Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women. METHODS: We performed a nested case-control study of healthy nulliparous women within the Calcium for Preeclampsia Prevention trial. The study included all 72 women who had preterm preeclampsia (<37 weeks), as well as 480 randomly selected women--120 women with preeclampsia at term (at > or =37 weeks), 120 women with gestational hypertension, 120 normotensive women who delivered infants who were small for gestational age, and 120 normotensive controls who delivered infants who were not small for gestational age. RESULTS: Circulating soluble endoglin levels increased markedly beginning 2 to 3 months before the onset of preeclampsia. After the onset of clinical disease, the mean serum level in women with preterm preeclampsia was 46.4 ng per milliliter, as compared with 9.8 ng per milliliter in controls (P<0.001). The mean serum level in women with preeclampsia at term was 31.0 ng per milliliter, as compared with 13.3 ng per milliliter in controls (P<0.001). Beginning at 17 weeks through 20 weeks of gestation, soluble endoglin levels were significantly higher in women in whom preterm preeclampsia later developed than in controls (10.2 ng per milliliter vs. 5.8 ng per milliliter, P<0.001), and at 25 through 28 weeks of gestation, the levels were significantly higher in women in whom term preeclampsia developed than in controls (8.5 ng per milliliter vs. 5.9 ng per milliliter, P<0.001). An increased level of soluble endoglin was usually accompanied by an increased ratio of sFlt1:PlGF. The risk of preeclampsia was greatest among women in the highest quartile of the control distributions for both biomarkers but not for either biomarker alone. CONCLUSIONS: Rising circulating levels of soluble endoglin and ratios of sFlt1:PlGF herald the onset of preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citationCirculating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationA Reversible Posterior Leukoencephalopathy Syndrome
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J.-L., & Caplan, L. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340803 · Cited by 3,340
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Preeclampsia: an endothelial cell disorder
Roberts, J. M., Taylor, R. N., Musci, T. J., Rodgers, G. M., Hubel, C. A., & McLaughlin, M. K. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90665-0 · Cited by 1,859
Soluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855
Self-citationSibai, B., Dekker, G., & Kupferminc, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17987-2 · Cited by 1,814
Self-citationCheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., & Letarte, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41732-2 · Cited by 836
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Trial of Calcium to Prevent Preeclampsia
Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370201 · Cited by 634
Self-citationTaylor, R. N., Grimwood, J., Taylor, R. S., McMaster, M. T., Fisher, S. J., & North, R. A. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.111 · Cited by 411
Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O., & Taketani, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021942 · Cited by 403
Hypertension in Pregnancy: Clinical-Pathological Correlations and Remote Prognosis
FISHER, K. A., LUGER, A., SPARGO, B. H., & LINDHEIMER, M. D. (1981) · Medicine · doi:10.1097/00005792-198107000-00002 · Cited by 378
Chaiworapongsa, T., Romero, R., Espinoza, J., Bujold, E., Mee Kim, Y., Gonçalves, L. F., Gomez, R., & Edwin, S. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.03.043 · Cited by 368
Self-citationReversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052954 · Cited by 365
Chaiworapongsa, T., Romero, R., Kim, Y. M., Kim, G. J., Kim, M. R., Espinoza, J., Bujold, E., Gonçalves, L., Gomez, R., Edwin, S., et al. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050400028816 · Cited by 359
Self-citationA longitudinal study of biochemical variables in women at risk of preeclampsia
Chappell, L. C., Seed, P. T., Briley, A., Kelly, F. J., Hunt, B. J., Charnock-Jones, D. S., Mallet, A. I., & Poston, L. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.122969 · Cited by 355
Urinary Placental Growth Factor and Risk of Preeclampsia
Levine, R. J. (2005) · JAMA · doi:10.1001/jama.293.1.77 · Cited by 339
Self-citationCigarette smoking during pregnancy and risk of preeclampsia: A systematic review
Conde-Agudelo, A., Althabe, F., Belizán, J. M., & Kafury-Goeta, A. C. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70341-8 · Cited by 337
Birth-Weight-for-Gestational-Age Patterns by Race, Sex, and Parity in the United States Population
Zhang, J. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00142-e · Cited by 295
Toporsian, M., Gros, R., Kabir, M. G., Vera, S., Govindaraju, K., Eidelman, D. H., Husain, M., & Letarte, M. (2005) · Circulation Research · doi:10.1161/01.res.0000159936.38601.22 · Cited by 250
Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia
Tidwell, S. C., Ho, H.-N., Chiu, W.-H., Torry, R. J., & Torry, D. S. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113129 · Cited by 231
Polliotti, B. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00338-7 · Cited by 229
Fisher, S. J. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-53 · Cited by 212
Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
Hertig, A., Berkane, N., Lefevre, G., Toumi, K., Marti, H.-P., Capeau, J., Uzan, S., & Rondeau, E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036715 · Cited by 188
Gougos, A., St Jacques, S., Greaves, A., O'Connell, P. J., d'Apice, A. J. F., Bühring, H.-J., Bernabeu, C., van Mourik, J. A., & Letarte, M. (1992) · International Immunology · doi:10.1093/intimm/4.1.83 · Cited by 184
Glomerular endotheliosis in normal pregnancy and pre-eclampsia
Strevens, H. (2003) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(03)02962-8 · Cited by 176
Buhimschi, C. S., Norwitz, E. R., Funai, E. F., Richman, S. M., Guller, S. M., Lockwood, C. J., & Buhimschi, I. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.052 · Cited by 153
Nicotine and angiogenesis: a new paradigm for tobacco‐related diseases
Cooke, J. P., & Bitterman, H. (2004) · Annals of Medicine · doi:10.1080/07853890310017576 · Cited by 145
Powers, R. W., Roberts, J. M., Cooper, K. M., Gallaher, M. J., Frank, M. P., Harger, G. F., & Ness, R. B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.038 · Cited by 131
Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights
Bdolah, Y., Sukhatme, V. P., & Karumanchi, S. A. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.07.003 · Cited by 113
Self-citationSmoking before pregnancy and risk of gestational hypertension and preeclampsia
England, L. J., Levine, R. J., Qian, C., Morris, C. D., Sibai, B. M., Catalano, P. M., Curet, L. B., & Klebanoff, M. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.122404 · Cited by 98
Self-citationTrial of calcium for preeclampsia prevention (CPEP): Rationale, design, and methods
Levine, R. J., Esterlitz, J., Raymond, E. G., DerSimonian, R., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., Clemens, J. D., et al. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00106-7 · Cited by 73
Self-citationSchmidt‐Lucke, C., Belgore, F. M., Reinhold, D., Ansorge, S., Klein, H., Schmidt-Lucke, J. A., & Lip, G. Y. H. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.046 · Cited by 34
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568
Self-citationPre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Self-citation
Metadata
- Authors
- Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., & Karumanchi, S. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-09-07
- Volume
- 355
- Issue
- 10
- Pages
- 992-1005
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2041999129
- Cited by
- 1,802
- References
- 35
- FWCI
- 99.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.